Tendon Injuries Treated with Pluristem's PLX Cells Demonstrate Favorable Properties
Pluristem Therapeutics Inc., a leading developer of placenta-based cell therapies, announced the results of a pre-clinical trial using the Company’s PLacental eXpanded (PLX) cells in tendon injury. Dr. Scott Rodeo and his orthopedic research team at New York’s Hospital for Special Surgery (HSS) studied the effects of PLX cells on rat patellar tendons that had sustained collagenase-induced injuries.
View full press release